Publications du CNR en 2018

Ahmad, N., Ahuja, S. D., Akkerman, O. W., Alffenaar, J.-W. C., Anderson, L. F., Baghaei, P., Bang, D., Barry, P. M., Bastos, M. L., Behera, D., Benedetti, A., Bisson, G. P., Boeree, M. J., Bonnet, M., Brode, S. K., Brust, J. C. M., Cai, Y., Caumes, E., Cegielski, J. P., Centis, R., Chan, P.-C., Chan, E. D., Chang, K.-C., Charles, M., Cirule, A., Dalcolmo, M. P., D’Ambrosio, L., de Vries, G., Dheda, K., Esmail, A., Flood, J., Fox, G. J., Fréchet-Jachym, M., Fregona, G., Gayoso, R., Gegia, M., Gler, M. T., Gu, S., Guglielmetti, L., Holtz, T. H., Hughes, J., Isaakidis, P., Jarlsberg, L., Kempker, R. R., Keshavjee, S., Khan, F. A., Kipiani, M., Koenig, S. P., Koh, W.-J., Kritski, A., Kuksa, L., Kvasnovsky, C. L., Kwak, N., Lan, Z., Lange, C., Laniado-Laborín, R., Lee, M., Leimane, V., Leung, C.-C., Leung, E. C.-C., Li, P. Z., Lowenthal, P., Maciel, E. L., Marks, S. M., Mase, S., Mbuagbaw, L., Migliori, G. B., Milanov, V., Miller, A. C., Mitnick, C. D., Modongo, C., Mohr, E., Monedero, I., Nahid, P., Ndjeka, N., O’Donnell, M. R., Padayatchi, N., Palmero, D., Pape, J. W., Podewils, L. J., Reynolds, I., Riekstina, V., Robert, J., Rodriguez, M., Seaworth, B., Seung, K. J., Schnippel, K., Shim, T. S., Singla, R., Smith, S. E., Sotgiu, G., Sukhbaatar, G., Tabarsi, P., Tiberi, S., Trajman, A., Trieu, L., Udwadia, Z. F., van der Werf, T. S., Veziris, N., Viiklepp, P., Vilbrun, S. C., Walsh, K., Westenhouse, J., Yew, W.-W., Yim, J.-J., Zetola, N. M., Zignol, M. and Menzies, D. (2018). Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. The Lancet 392, 821–834, http://doi.org/10.1016/S0140-6736(18)31644-1.

Ates, L. S., Dippenaar, A., Sayes, F., Pawlik, A., Bouchier, C., Ma, L., Warren, R. M., Sougakoff, W., Majlessi, L., van Heijst, J. W. J., Brossier, F. and Brosch, R. (2018). Unexpected Genomic and Phenotypic Diversity of Mycobacterium africanum Lineage 5 Affects Drug Resistance, Protein Secretion, and Immunogenicity. Genome Biol Evol 10, 1858–1874, http://doi.org/10.1093/gbe/evy145.

Bastard, M., Guglielmetti, L., Huerga, H., Hayrapetyan, A., Khachatryan, N., Yegiazaryan, L., Faqirzai, J., Hovhannisyan, L., Varaine, F. and Hewison, C. (2018). Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They? Am J Respir Crit Care Med 198, 1228–1231, http://doi.org/10.1164/rccm.201801-0019LE.

Bergot, E., Abiteboul, D., Andréjak, C., Antoun, F., Barras, E., Blanc, F.-X., Bourgarit, A., Charlois-Ou, C., Delacourt, C., Dirou, S., Gerin, M., Guerin, S., Haustraete, É., Henry, B., Lucet, J.-C., Maitre, T., Morin, J., Le Palud, P., Pommelet, V., Rivoisy, C., Robert, J., Veziris, N. and Herrmann, J.-L. (2018). [Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis]. Rev Mal Respir 35, 852–858, http://doi.org/10.1016/j.rmr.2018.08.007.

Blanc, F.-X., Dirou, S., Morin, J. and Veziris, N. (2018). [Interferon gamma release assay tests for the diagnosis of active tuberculosis]. Rev Mal Respir 35, 894–899, http://doi.org/10.1016/j.rmr.2018.08.016.

Cambau, E. (2018). Antileprosy drugs: mode of action and mechanisms. In: International textbook of leprosy, URL: https://internationaltextbookofleprosy.org/chapter/anti-leprosy-drugs-modes-action-and-mechanisms-resistance-mycobacterium-leprae [Accessed May 2022].

Cambau, E., Saunderson, P., Matsuoka, M., Cole, S. T., Kai, M., Suffys, P., Rosa, P. S., Williams, D., Gupta, U. D., Lavania, M., Cardona-Castro, N., Miyamoto, Y., Hagge, D., Srikantam, A., Hongseng, W., Indropo, A., Vissa, V., Johnson, R. C., Cauchoix, B., Pannikar, V. K., Cooreman, E. a. W. D., Pemmaraju, V. R. R., Gillini, L., Kriswamati, A., Al-Samie, A. R., Issoufou, A., Tiendrebeogo, A., Kingalu, A., Randrianantoandro, A., Kumar, A., Chauffour, A., Win, A. A., Pandey, B., Agrawal, C. M., Widaningrum, C., Schmotzer, C., Kafando, C., Bhandari, C. M., Sema, C., Vidanagama, D. S., Scollard, D. M., Beyene, D., Morelo, E. F., Kassa, E. D., Ramarolahy, E. B., Claco, E., Villalon, E. E., Sidibe, F., Sakho, F., Abdoulaye, F., Guilengue, F. F., Gajete, F., Babu, G. R., Moussa, G., Thakur, G. D., Cabanos, G., Sock, G., Clugston, G., Zaidy, H., Watanabe, H., Kawuma, H. J., Mallari, I. B., Goulart, I. M. B., Ahamed, I., Subbanna, J., Houzeo, J. G., Luengu, J. N. M., Bertolli, J., Lloyd-Owen, J., Matheu, J., Brunelli, J. P., Alzate, J. C. B., Neupane, Kapil Dev, Osuga, K., Yamaguchi, K., Azam, K., Lin, K. M., Momoudu, K., Kyaw, K., Bide, L., Doanh, L. H., My, L. H., Shah, M., Kodio, M., Sidibe, M., Ebenezer, M., Grossi, M. A. de F., Balagon, M. F., Canlonon, M., Makino, M., Htoo, M. M., Ahmed, M. J., Nadine, M.-M., Roferos, F. O., Krismawati, H., Thida, M., Htoon, M. T., Neupane, K. D., Phuc, N. H. N., Van, N. H., Hai, N. P. N., Ishii, N., Soe, O., Amiel, O., Tossou, O., Konare, O., Joshi, P. L., Rao, P. V. R., Krishnamurthy, P., Brennan, P. J., Busso, P., Bhatia, R., Andrianarivelo, M. R., Ramdas, D. R., Chabi, R., Gusmao, R., DjupuriIzwardy, R., Soares, R. C. F. R., Jhadav, R., Buhrer, S., Cho, S.-N. R., Jianping, S., Lzumi, S., Barua, S., Chaitanya, S., Tiendrebeogo, S. M. R., Khang, T. H., Gillis, T. P., Mori, T., Vijayalakshmi, V., Kamara, V. D., Wei, W., Smith, W. C. S., Li, W., Lew, W., Al-Qubati, Y., Suzuki, Y. and Nanba, Y. (2018). Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15. Clinical Microbiology and Infection 24, 1305–1310, http://doi.org/10.1016/j.cmi.2018.02.022.

Chauffour, A., Lecorche, E., Reibel, F., Mougari, F., Raskine, L., Aubry, A., Jarlier, V. and Cambau, E. (2018). Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015. Clinical Microbiology and Infection 24, 1213.e5-1213.e8, http://doi.org/10.1016/j.cmi.2018.06.004.

Coolen-Allou, N., Touron, T., Belmonte, O., Gazaille, V., Andre, M., Allyn, J., Picot, S., Payet, A. and Veziris, N. (2018). Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients. Antimicrobial Agents and Chemotherapy 62, e00395-18, http://doi.org/10.1128/AAC.00395-18.

D’Ambrosio, L., Bothamley, G., Caminero Luna, J. A., Duarte, R., Guglielmetti, L., Muñoz Torrico, M., Payen, M. C., Saavedra Herrera, N., Salazar Lezama, M. A., Skrahina, A., Tadolini, M., Tiberi, S., Veziris, N. and Migliori, G. B. (2018). Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond. Pulmonology 24, 132–141, http://doi.org/10.1016/j.rppnen.2017.10.005.

Gras, J., De Castro, N., Montlahuc, C., Champion, L., Scemla, A., Matignon, M., Lachâtre, M., Raskine, L., Grall, N., Peraldi, M. N. and Molina, J. M. (2018). Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area. Transplant Infectious Disease 20, e12943, http://doi.org/10.1111/tid.12943.

Griffith, D. E., Eagle, G., Thomson, R., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O’Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L., Codecasa, L. R., Hill, A. T., Ruoss, S. J., Yim, J.-J., Ringshausen, F. C., Field, S. K., Philley, J. V., Wallace, R. J., van Ingen, J., Coulter, C., Nezamis, J. and Winthrop, K. L. (2018). Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med 198, 1559–1569, http://doi.org/10.1164/rccm.201807-1318OC.

Guglielmetti, L., Barkane, L., Dû, D. L., Marigot-Outtandy, D., Robert, J., Veziris, N., Yazdanpanah, Y., Kuksa, L., Caumes, E. and Fréchet-Jachym, M. (2018). Safety and efficacy of exposure to bedaquiline−delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia. European Respiratory Journal 51, 1702550, http://doi.org/10.1183/13993003.02550-2017.

Guglielmetti, L., Tiberi, S., Burman, M., Kunst, H., Wejse, C., Togonidze, T., Bothamley, G. and Lange, C. (2018). QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study. European Respiratory Journal 52, http://doi.org/10.1183/13993003.00537-2018.

Guglielmetti, L., Veziris, N., Aubry, A., Brossier, F., Bernard, C., Sougakoff, W., Jarlier, V., Robert, J. and surveillance, for the L. N. for M. (2018). Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study., doi:info:doi/10.5588/ijtld.17.0387.

Kouriba, B., Ouwe Missi Oukem-Boyer, O., Traoré, B., Touré, A., Raskine, L. and Babin, F. X. (2018). Installing biosafety level 3 containment laboratories in low- and middle-income countries: challenges and prospects from Mali’s experience. New Microbes New Infect 26, S74–S77, http://doi.org/10.1016/j.nmni.2018.05.011.

Lecorche, E., Haenn, S., Mougari, F., Kumanski, S., Veziris, N., Benmansour, H., Raskine, L., Moulin, L., Cambau, E., Aubry, A., Brossier, F., Chauffour, A., Jaffre, J., Jarlier, V., Robert, J. and Sougakoff, W. (2018). Comparison of methods available for identification of Mycobacterium chimaera. Clinical Microbiology and Infection 24, 409–413, http://doi.org/10.1016/j.cmi.2017.07.031.

Levi, L. I., Schlemmer, F., de Castro, N., Brun, O., Veziris, N., Argemi, X., Roupret, M., Launay, O., Bergeron, A. and Groh, M. (2018). Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter? Médecine et Maladies Infectieuses, http://doi.org/10.1016/j.medmal.2018.11.014.

Machado, D., Lecorche, E., Mougari, F., Cambau, E. and Viveiros, M. (2018). Insights on Mycobacterium leprae Efflux Pumps and Their Implications in Drug Resistance and Virulence. Front Microbiol 9, http://doi.org/10.3389/fmicb.2018.03072.

Maitre, T., Robert, J. and Veziris, N. (2018). Introduction: épidémiologie de la tuberculose et de l’infection tuberculeuse latente. Rev Mal Respir 35, 859–861, http://doi.org/10.1016/j.rmr.2018.08.009.

Mieras, L. F., Taal, A. T., van Brakel, W. H., Cambau, E., Saunderson, P. R., Smith, W. C. S., Prakoeswa, C. R. S., Astari, L., Scollard, D. M., do Nascimento, D. C., Grosset, J., Kar, H. K., Izumi, S., Gillini, L., Virmond, M. C. L. and Sturkenboom, M. G. G. (2018). An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++. BMC Infectious Diseases 18, 506, http://doi.org/10.1186/s12879-018-3402-4.

Rueda, D., Bernard, C., Gandy, L., Capton, E., Boudjelloul, R., Brossier, F., Veziris, N., Zimic, M. and Sougakoff, W. (2018). Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis. Int J Mycobacteriol 7, 16–25, http://doi.org/10.4103/ijmy.ijmy_187_17.

Sayes, F., Blanc, C., Ates, L. S., Deboosere, N., Orgeur, M., Le Chevalier, F., Gröschel, M. I., Frigui, W., Song, O.-R., Lo-Man, R., Brossier, F., Sougakoff, W., Bottai, D., Brodin, P., Charneau, P., Brosch, R. and Majlessi, L. (2018). Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors. Cell Reports 23, 1072–1084, http://doi.org/10.1016/j.celrep.2018.03.125.

Scherr, N., Bieri, R., Thomas, S. S., Chauffour, A., Kalia, N. P., Schneide, P., Ruf, M.-T., Lamelas, A., Manimekalai, M. S. S., Grüber, G., Ishii, N., Suzuki, K., Tanner, M., Moraski, G. C., Miller, M. J., Witschel, M., Jarlier, V., Pluschke, G. and Pethe, K. (2018). Targeting the Mycobacterium ulcerans cytochrome bc 1 : aa 3 for the treatment of Buruli ulcer. Nature Communications 9, 5370, http://doi.org/10.1038/s41467-018-07804-8.

van Ingen, J., Aksamit, T., Andrejak, C., Böttger, E. C., Cambau, E., Daley, C. L., Griffith, D. E., Guglielmetti, L., Holland, S. M., Huitt, G. A., Koh, W.-J., Lange, C., Leitman, P., Marras, T. K., Morimoto, K., Olivier, K. N., Santin, M., Stout, J. E., Thomson, R., Tortoli, E., Wallace, R. J., Winthrop, K. L. and Wagner, D. (2018). Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. European Respiratory Journal 51, 1800170, http://doi.org/10.1183/13993003.00170-2018.

Walker, T. M., Merker, M., Knoblauch, A. M., Helbling, P., Schoch, O. D., Werf, M. J. van der, Kranzer, K., Fiebig, L., Kröger, S., Haas, W., Hoffmann, H., Indra, A., Egli, A., Cirillo, D. M., Robert, J., Rogers, T. R., Groenheit, R., Mengshoel, A. T., Mathys, V., Haanperä, M., Soolingen, D. van, Niemann, S., Böttger, E. C., Keller, P. M., Avsar, K., Bauer, C., Bernasconi, E., Borroni, E., Brusin, S., Dévis, M. C., Crook, D. W., Dedicoat, M., Fitzgibbon, M., Gagneux, S., Geiger, F., Guthmann, J.-P., Hendrickx, D., Hoffmann-Thiel, S., Ingen, J. van, Jackson, S., Jaton, K., Lange, C., Stalder, J. M., O’Donnell, J., Opota, O., Peto, T. E. A., Preiswerk, B., Roycroft, E., Sato, M., Schacher, R., Schulthess, B., Smith, E. G., Soini, H., Sougakoff, W., Tagliani, E., Utpatel, C., Veziris, N., Wagner-Wiening, C. and Witschi, M. (2018). A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. The Lancet Infectious Diseases 18, 431–440, http://doi.org/10.1016/S1473-3099(18)30004-5.

World Health Organization (2018). Technical Report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis, WHO, Geneva, URL: https://apps.who.int/iris/rest/bitstreams/1098393/retrieve.